Skip to main content
. 2003 May;47(5):1598–1603. doi: 10.1128/AAC.47.5.1598-1603.2003

FIG. 5.

FIG. 5.

Pharmacokinetic-pharmacodynamic dose modeling to effect for GISA isolates. ED50, dose correlating to 50% bacterial density reduction from growth control; ED80, dose correlating to 80% bacterial density reduction from growth control. •, GISA-992 bacterial densities at 48 h; ○, GISA-147398 bacterial densities at 48 h.